Hangzhou Tigermed Consulting Co., Ltd

DB:5HZ1 Stock Report

Market Cap: €6.2b

Hangzhou Tigermed Consulting Co., Ltd Company Information

Hangzhou Tigermed Consulting Co., Ltd's employee growth, exchange listings and data sources


Key Information

  • Name: Hangzhou Tigermed Consulting Co., Ltd
  • Ticker: 5HZ1
  • Exchange: DB
  • Founded: 2004
  • Industry: Life Sciences Tools and Services
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: CN¥47.401b
  • Listing Market Cap: CN¥6.247b
  • Shares Outstanding: 861.29m
  • Website: https://www.tigermedgrp.com

Number of Employees


Location

  • Hangzhou Tigermed Consulting Co., Ltd
  • Shengda Science Park, Building A
  • Floor 18
  • Hangzhou
  • Zhejiang Province
  • 310051
  • China


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
300347SZSE (Shenzhen Stock Exchange)YesDomestic SharesCNCNYAug 2012
300347XSEC (Shenzhen Stock Exchange - Shenzhen-Hong Kong Stock Connect)YesDomestic SharesCNCNYAug 2012
3347SHSC (Stock Exchange of Hong Kong Limited - Shanghai - Hong Kong Stock Connect)Foreign Shares-Foreign ListedHKHKDAug 2020
3347SZSC (The Stock Exchange of Hong Kong - Shenzhen - Hong Kong Stock Connect)Foreign Shares-Foreign ListedHKHKDAug 2020
3347SEHK (The Stock Exchange of Hong Kong Ltd.)Foreign Shares-Foreign ListedHKHKDAug 2020
5HZ1DB (Deutsche Boerse AG)Foreign Shares-Foreign ListedDEEURAug 2020
HNGZ.YOTCPK (Pink Sheets LLC)UNSPONSORED ADRUSUSDJan 2021

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/12/24 17:29
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 17:29
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hangzhou Tigermed Consulting Co., Ltd is covered by 39 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yang LuoBOCI Research Ltd.
Linda LuBOCI Research Ltd.
Bo LiBofA Global Research